Publication | Closed Access

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

Hematological MalignancyMedicineHematologyRetrospective AnalysisPathologyMyeloid NeoplasiaMutation Status-Lmc GroupOncologyRadiation OncologyCancer ResearchHealth Sciences